These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38163651)

  • 1. Association Between Executive Dysfunction-Related Activities of Daily Living Disability and Clinical Dementia Rating Domain Patterns in Patients With Vascular Dementia and Age-Matched Patients With Alzheimer's Dementia.
    Jun BS; Kim KM; Yang HJ; Park JH
    Psychiatry Investig; 2023 Dec; 20(12):1126-1132. PubMed ID: 38163651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in instrumental activities of daily living between mild cognitive impairment and Alzheimer's disease: A study using a detailed executive function assessment.
    Maeshima S; Osawa A; Kondo I; Kamiya M; Ueda I; Sakurai T; Arai H
    Geriatr Gerontol Int; 2021 Dec; 21(12):1111-1117. PubMed ID: 34643324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional assessment staging (FAST) in Korean patients with Alzheimer's disease.
    Na HR; Kim SY; Chang YH; Park MH; Cho ST; Han IW; Kim TY; Hwang SA
    J Alzheimers Dis; 2010; 22(1):151-8. PubMed ID: 20847407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage-independent and stage-specific phenotypic differences between vascular dementia and Alzheimer's Disease.
    Chan M; Lim WS; Sahadevan S
    Dement Geriatr Cogn Disord; 2008; 26(6):513-21. PubMed ID: 19052451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological deficits in vascular dementia vs Alzheimer's disease. Frontal lobe deficits prominent in vascular dementia.
    Kertesz A; Clydesdale S
    Arch Neurol; 1994 Dec; 51(12):1226-31. PubMed ID: 7986178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of neuropsychological profiles in patients with Alzheimer's disease and mixed dementia.
    Kang HS; Kwon JH; Kim S; Na DL; Kim SY; Lee JH; Han SH; Choi SH; Kim S; Carroll BJ; Kim DK
    J Neurol Sci; 2016 Oct; 369():134-138. PubMed ID: 27653879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study.
    Hallikainen I; Martikainen J; Lin PJ; Cohen JT; Lahoz R; Välimäki T; Hongisto K; Väätäinen S; Vanhanen M; Neumann PJ; Hänninen T; Koivisto AM
    Dement Geriatr Cogn Dis Extra; 2014; 4(3):494-508. PubMed ID: 25685140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological performance in Alzheimer's disease and vascular dementia: comparisons in a memory clinic population.
    Baillon S; Muhommad S; Marudkar M; Suribhatla S; Dennis M; Spreadbury C; Munro D; Lindesay J
    Int J Geriatr Psychiatry; 2003 Jul; 18(7):602-8. PubMed ID: 12833304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
    Kim JM; Lyons D; Shin IS; Yoon JS
    Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test.
    Allone C; Lo Buono V; Corallo F; Bonanno L; Palmeri R; Di Lorenzo G; Marra A; Bramanti P; Marino S
    Psychogeriatrics; 2018 Mar; 18(2):123-131. PubMed ID: 29417704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DEX and executive dysfunction in activities of daily living in Alzheimer's disease and frontotemporal dementia].
    Piquard A; Derouesné C; Meininger V; Lacomblez L
    Psychol Neuropsychiatr Vieil; 2010 Sep; 8(3):215-24; quiz 225-7. PubMed ID: 20739260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.
    Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K
    Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia.
    D'Onofrio G; Panza F; Sancarlo D; Addante F; Solfrizzi V; Cantarini C; Mangiacotti A; Lauriola M; Cascavilla L; Paris F; Lozupone M; Daniele A; Greco A; Seripa D
    J Alzheimers Dis; 2018; 62(2):699-711. PubMed ID: 29480171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study on the clinical features of Alzheimer's disease and vascular dementia].
    Chen X; Zhang ZX; Huang JB; Wen HB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):122-7. PubMed ID: 15171546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive functioning in Alzheimer's disease and vascular dementia.
    McGuinness B; Barrett SL; Craig D; Lawson J; Passmore AP
    Int J Geriatr Psychiatry; 2010 Jun; 25(6):562-8. PubMed ID: 19810010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.
    Grober E; Qi Q; Kuo L; Hassenstab J; Perrin RJ; Lipton RB
    J Alzheimers Dis; 2021; 80(1):185-195. PubMed ID: 33492286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.